ClearPoint Neuro (CLPT) Income from Continuing Operations (2011 - 2026)
ClearPoint Neuro (CLPT) posted Income from Continuing Operations of 9552000.0 for Q1 2026, down 23.2% sequentially from 7753000.0 in Q4 2025, and down 58.51% YoY from 23024140.8 in Q1 2025.
ClearPoint Neuro (CLPT) Income from Continuing Operations (2011 - 2026) Analysis & Trends
ClearPoint Neuro has reported Income from Continuing Operations for 15 years, with the latest figure at 9552000.0 in Q1 2026.
- Quarterly Income from Continuing Operations fell 58.51% year-over-year to 9552000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 29033000.0 (down 44.21% YoY) and the FY2025 annual result came in at 25507000.0, down 39.75% from the prior year.
- Income from Continuing Operations declined to 9552000.0 in Q1 2026 per CLPT's latest filing, from 7753000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 4146000.0 in Q1 2024 and troughed at 14683000.0 in Q2 2022.
- A 5-year average of 7587000.0 and a median of 6026000.0 in 2025 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations jumped 62.47% in 2024, then plunged 64.12% in 2025.
- Over 5 years, Income from Continuing Operations stood at 4641000.0 in 2022, then dropped by 5.47% to 4895000.0 in 2023, then advanced by 3.49% to 4724000.0 in 2024, then tumbled by 64.12% to 7753000.0 in 2025, then slipped by 23.2% to 9552000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 9552000.0, 7753000.0, and 5891000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 201.00 Mn |
| 10 | ClearPoint Neuro | 467.73 Mn | 438.33 Mn | 6.71 Mn | -11.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.34 Mn |
| Mar 31, 2026 | -9.55 Mn |
| Dec 31, 2025 | -7.75 Mn |
| Sep 30, 2025 | -5.89 Mn |
| Jun 30, 2025 | -5.84 Mn |
| Mar 31, 2025 | -6.03 Mn |
| Dec 31, 2024 | -4.72 Mn |
| Sep 30, 2024 | -4.97 Mn |
| Jun 30, 2024 | -4.41 Mn |
| Mar 31, 2024 | -4.15 Mn |
| Dec 31, 2023 | -4.90 Mn |
| Sep 30, 2023 | -6.76 Mn |
| Jun 30, 2023 | -11.23 Mn |
| Mar 31, 2023 | -11.05 Mn |
| Dec 31, 2022 | -4.64 Mn |
| Sep 30, 2022 | -11.05 Mn |
| Jun 30, 2022 | -14.68 Mn |
| Mar 31, 2022 | -11.36 Mn |
| Dec 31, 2021 | -4.46 Mn |
| Sep 30, 2021 | -19.13 Mn |